Zhejiang Int'L Group Co Ltd (000411) - Total Liabilities
Based on the latest financial reports, Zhejiang Int'L Group Co Ltd (000411) has total liabilities worth CN¥11.95 Billion CNY (≈ $1.75 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Zhejiang Int'L Group Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Zhejiang Int'L Group Co Ltd - Total Liabilities Trend (1993–2024)
This chart illustrates how Zhejiang Int'L Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 000411 asset base.
Zhejiang Int'L Group Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Int'L Group Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Pakuwon Jati Tbk
JK:PWON
|
Indonesia | Rp10.08 Trillion |
|
LOGAN GROUP HD -10
F:5LP
|
Germany | €167.44 Billion |
|
Companhia de Saneamento do Paraná - SANEPAR
SA:SAPR3
|
Brazil | R$14.43 Billion |
|
AGRANA Beteiligungs-Aktiengesellschaft
VI:AGR
|
Austria | €1.42 Billion |
|
SMU S.A
SN:SMU
|
Chile | CL$1.68 Trillion |
|
EuroTeleSites AG
VI:ETS
|
Austria | €1.69 Billion |
|
Walton Advanced Engineering Inc
TW:8110
|
Taiwan | NT$4.31 Billion |
|
Ning Xia Yin Xing Energy Co Ltd
SHE:000862
|
China | CN¥4.29 Billion |
Liability Composition Analysis (1993–2024)
This chart breaks down Zhejiang Int'L Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Zhejiang Int'L Group Co Ltd (000411) balance sheet quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Int'L Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Int'L Group Co Ltd (1993–2024)
The table below shows the annual total liabilities of Zhejiang Int'L Group Co Ltd from 1993 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥9.42 Billion ≈ $1.38 Billion |
+3.23% |
| 2023-12-31 | CN¥9.13 Billion ≈ $1.34 Billion |
-1.65% |
| 2022-12-31 | CN¥9.28 Billion ≈ $1.36 Billion |
+6.31% |
| 2021-12-31 | CN¥8.73 Billion ≈ $1.28 Billion |
+8.52% |
| 2020-12-31 | CN¥8.04 Billion ≈ $1.18 Billion |
+3.16% |
| 2019-12-31 | CN¥7.80 Billion ≈ $1.14 Billion |
+12.86% |
| 2018-12-31 | CN¥6.91 Billion ≈ $1.01 Billion |
-3.75% |
| 2017-12-31 | CN¥7.18 Billion ≈ $1.05 Billion |
+35.68% |
| 2016-12-31 | CN¥5.29 Billion ≈ $774.14 Million |
+14.77% |
| 2015-12-31 | CN¥4.61 Billion ≈ $674.50 Million |
+19.90% |
| 2014-12-31 | CN¥3.84 Billion ≈ $562.55 Million |
+8.22% |
| 2013-12-31 | CN¥3.55 Billion ≈ $519.82 Million |
+16.00% |
| 2012-12-31 | CN¥3.06 Billion ≈ $448.13 Million |
+10.87% |
| 2011-12-31 | CN¥2.76 Billion ≈ $404.19 Million |
+37.58% |
| 2010-12-31 | CN¥2.01 Billion ≈ $293.79 Million |
+33.73% |
| 2009-12-31 | CN¥1.50 Billion ≈ $219.68 Million |
+26.21% |
| 2008-12-31 | CN¥1.19 Billion ≈ $174.06 Million |
+14.80% |
| 2007-12-31 | CN¥1.04 Billion ≈ $151.61 Million |
+11.91% |
| 2006-12-31 | CN¥925.87 Million ≈ $135.48 Million |
+12.78% |
| 2005-12-31 | CN¥820.92 Million ≈ $120.13 Million |
+15.31% |
| 2004-12-31 | CN¥711.94 Million ≈ $104.18 Million |
+20.17% |
| 2003-12-31 | CN¥592.43 Million ≈ $86.69 Million |
-1.75% |
| 2002-12-31 | CN¥603.00 Million ≈ $88.24 Million |
+18.40% |
| 2001-12-31 | CN¥509.30 Million ≈ $74.53 Million |
+107.15% |
| 2000-12-31 | CN¥245.86 Million ≈ $35.98 Million |
-18.12% |
| 1999-12-31 | CN¥300.27 Million ≈ $43.94 Million |
+13.09% |
| 1998-12-31 | CN¥265.52 Million ≈ $38.85 Million |
+7.25% |
| 1997-12-31 | CN¥247.57 Million ≈ $36.23 Million |
+5.39% |
| 1996-12-31 | CN¥234.91 Million ≈ $34.37 Million |
+22.78% |
| 1995-12-31 | CN¥191.33 Million ≈ $28.00 Million |
+72.12% |
| 1994-12-31 | CN¥111.16 Million ≈ $16.27 Million |
+19.50% |
| 1993-12-31 | CN¥93.02 Million ≈ $13.61 Million |
-- |
About Zhejiang Int'L Group Co Ltd
Zhejiang Int'l Group Co.,Ltd. engages in the wholesale and retail of pharmaceuticals and medical devices. It offers chemical drugs, biological products, and Chinese patent medicine. The company was founded in 1950 and is based in Hangzhou, China.